Comments on: Is Lipitor driving Pfizer and Sankyo's Ranbaxy bidding? http://www.thinkipstrategy.com/ipthinktank/331/is-lipitor-driving-pfizer-and-sankyos-ranbaxy-bidding/ Trusted advisors to the world's most innovative companies Mon, 16 Jan 2012 09:10:00 +0000 hourly 1 http://wordpress.org/?v=3.2.1 By: Duncan http://www.thinkipstrategy.com/ipthinktank/331/is-lipitor-driving-pfizer-and-sankyos-ranbaxy-bidding/comment-page-1/#comment-1244 Duncan Mon, 16 Jun 2008 12:48:59 +0000 http://localhost:100/thinkipstrategy/?p=331#comment-1244 <p>Nice supposition, but no.</p><p>Is the answer from a regular reader of this blog.  She points out that Daiichi seem to have won the bidding war. </p><p>Also, more tellingly - Pfizer could launch a generic Lipitor at any time.  </p><p>[Duncan's note - Unsurprisingly, <a href="https://www.greenstonellc.com/greenstone/html/greenstone/pressreleases.htm" rel="nofollow">Greenstone</a>, Pfizer's Generic subsidiary, doesn't have Atorvastatin listed in it's <a href="https://www.greenstonellc.com/greenstone/html/greenstone/Greenstone Product Catalog.pdf" rel="nofollow">product catalogue</a> yet - it's a bit early...</p><p>I guess this part of the debate might come down to how effective the Greenstone marketing arm would be as compared to Ranbaxy's for the sale of generic Atorvastatin...]</p> Nice supposition, but no.

Is the answer from a regular reader of this blog.  She points out that Daiichi seem to have won the bidding war.

Also, more tellingly – Pfizer could launch a generic Lipitor at any time. 

[Duncan's note - Unsurprisingly, Greenstone, Pfizer's Generic subsidiary, doesn't have Atorvastatin listed in it's product catalogue yet - it's a bit early...

I guess this part of the debate might come down to how effective the Greenstone marketing arm would be as compared to Ranbaxy's for the sale of generic Atorvastatin...]

]]>